Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate

Not Applicable

Withdrawn

• Conditions: Blood Loss, Surgical; Intraoperative Complications; Re-operation Rates in Patients With Aspirin Treatment
• Interventions: Drug: transurethral surgery with or without aspirin

• Registration Number: NCT00861367
• Lead Sponsor: University Hospital, Basel, Switzerland

Brief Summary

Aspirin is very common in older patients. Therefore many of the investigators patients have aspirin. The aim of the study is to proof that Transurethral Surgery of the bladder or the prostate can be performed with aspirin.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-09
• Primary Completion: 2009-01
• Study Completion: 2009-01
• Study First Submitted: 2009-03-12
• Study First Submitted QC: 2009-03-12
• Study First Posted: 2009-03-13
• Status Verified: 2024-03
• Last Update Submitted: 2024-03-18
• Last Update Posted: 2024-03-19

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Transurethral surgery of the bladder or prostate, informed consent, age over 18

Exclusion Criteria

• Oral anticoagulation,

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1	transurethral surgery with or without aspirin	aspirin 100mg
2	transurethral surgery with or without aspirin	empty capsule

Primary Outcome Measures

Name	Time	Method
Blood loss	intraoperative, 6 hours post op, 3 days postop

Secondary Outcome Measures

Name	Time	Method
Reoperation rates	during hospitalization

Trial Locations

Locations (1)

Urologische Universitätsklinik Basel-Liestal; 🇨🇭 Liestal, Switzerland